Tag: Oncotype DX

How a Community Based Cancer Center Took the Leap Into the 21st Century Through Technology Backed Tumor Boards

| December 4, 2017 | 2 Comments

Multi-disciplinary tumor boards (MDT) have been the highlight of cancer programs for years and enable the delivery of well-coordinated care and bring the expertise of numerous specialties to each patient case. Previous studies have shown that 40% of the time, the primary oncologist or provider’s plan changes as a result of this multi-disciplinary discussion. There […]

Continue Reading

National Cancer Institute Awards $3.3 Million 5-Year Academic-Industry Grant to Inspirata and Case Western Reserve University for Breast Cancer Risk Assessment Assay

| July 11, 2016 | 0 Comments

Inspirata continues to make news this month with a grant announcement from the NCI for $3.3 million over 5 years to fund the development of image analysis methods to mine sub-visual image features with whole slide imaging in a partnership with Case Western Reserve University (CWRU). Dr. Anant Madabhushi is the Principle Investigator, Professor and Director […]

Continue Reading

Philips and Genomic Health Announce Digital Pathology Partnership

| October 13, 2015 | 0 Comments

Interesting news yesterday from Philips and Genomic Health announcing a collaboration of their technologies. For many years I have thought one of the main drivers for digital pathology adoption in an increasing trend towards personalized, predictive and pre-emptive medicine would be the need for a bridge between morphology and molecular.  Often times the paraffin block […]

Continue Reading